Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CBD Cigarettes Instead of Normal Cigarettes Against Enforcement Measures, for Improved Acute Treatment and for Harm Reduction of Smoking - Innovative Treatment for Schizophrenia

NCT04700930 is registered in ClinicalTrials.gov with Psychiatric Hospital of the University of Basel as lead sponsor.

NCT NCT04700930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CBD Cigarettes Instead of Normal Cigarettes Against Enforcement Measures, for Improved Acute Treatment and for Harm Reduction of Smoking - Innovative Treatment for Schizophrenia
Lead sponsor
Psychiatric Hospital of the University of Basel
Phase
Not applicable
Overall status
Unknown status
Start date
October 4, 2018
Completion date
October 31, 2021
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

harm reduction, schizophrenia and other psychotic disorders